Fludeoxyglucose F 18 Injection
Product Images NDC 29998-001

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose F 18 (NDC 29998-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kettering Medical Center, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lead Safe Label (Safe Label)

Fludeoxyglucose F18 Injection label showing lot number, calibration date and time, expiration date and time, and activity concentration in mCi/mL at end of synthesis (EOS). The label includes storage instructions and manufacturing details by Kettering Medical Center. It has a radioactive material warning symbol.*

FDA Label Image

Image Description (Fludeoxyglucose 01)

Chemical structure of Fludeoxyglucose F 18, showing the arrangement of carbon, hydrogen, oxygen, and fluorine atoms, including a radioactive fluorine-18 isotope indicated in the molecule.*

FDA Label Image

Principal Display Panel (30 mL Vial Label)

Label for Fludeoxyglucose F18 Injection by Kettering Medical Center, specified for intravenous use only. The label includes radioactive material warning, product identification as [18F] FDG, lot number 181031F1, and an expiration date of 10/31/2018.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.